Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review

Exploratory Study of the Prevalence and Clinical Significance of Tobramycin-Mediated Biofilm Induction in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

(2010) D. Elliott et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of the Combination of Tobramycin and a Macrolide in an In Vitro Pseudomonas aeruginosa Mature Biofilm Model

(2010) M. Tre-Hardy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceramide in Pseudomonas aeruginosa Infections and Cystic Fibrosis

(2010) Katrin Anne Becker et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications

(2010) S. Kanoh et al.   CLINICAL MICROBIOLOGY REVIEWS

Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial

(2010) Lisa Saiman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immunomodulatory Effects of Macrolide Antibiotics – Part 1: Biological Mechanisms

(2010) J. Altenburg et al.   RESPIRATION

Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial

(2009) S.K. Kabra et al.   Journal of Cystic Fibrosis

Effects of prolonged use of azithromycin in patients with cystic fibrosis: A meta-analysis

(2009) D.F. Florescu et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

P. aeruginosa Biofilms in CF Infection

(2008) Victoria E. Wagner et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection

(2008) Gratiana Steinkamp et al.   RESPIRATORY MEDICINE